論文 - 詳細
| RRC ID | 67694 |
|---|---|
| 著者 | Tazawa H, Suzuki T, Saito A, Ishikawa A, Komo T, Sada H, Shimada N, Hadano N, Onoe T, Sudo T, Shimizu Y, Kuraoka K, Tashiro H. |
| タイトル | Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer. |
| ジャーナル | J Gastrointest Surg |
| Abstract |
BACKGROUND:Transmembrane serine protease 4 (TMPRSS4) belongs to the family of type II transmembrane serine proteases that are known to be upregulated in many malignant tumors. However, there is a paucity of studies documenting the clinical impact and biological effects of TMPRSS4 on gastric cancer (GC) patients who underwent surgery. METHODS:Tissues samples were obtained from 105 patients with GC who underwent gastrectomy followed by adjuvant chemotherapy, excluding those at stage I. The expression of TMPRSS4 was examined through immunohistochemical analysis. The association between TMPRSS4 expression and clinico-pathological features as well as prognosis was assessed. Moreover, the effects of TMPRSS4 expression on cell migration and sensitivity to 5-FU were investigated. RESULTS:The expression rate of TMPRSS4 was 56.3% (59/105) in GC cases. The expression of TMPRSS4 was positively correlated with the depth of tumor (T) and venous (V) invasion. The 5-year overall survival (OS) and recurrence-free survival (RFS) rates of the TMPRSS4-positive group was significantly lower than that of the TMPRSS4-negative group (p=0.0001 and p=0.005, respectively). Especially, there was significant differences in OS and RFS of patients with stage III cancer between the two groups (p=0.0064 and 0.012, respectively). Multivariate analysis demonstrated that TMPRSS4 expression and the stage of cancer were crucial prognostic factors for RFS. TMPRSS4-silenced GC cells exhibited increased sensitivity to 5-FU when compared with the non-specific control siRNA-transfected cells. CONCLUSION:TMPRSS4 can be considered as a potential prognostic biomarker, especially for stage III, and a promising therapeutic target for GC. |
| 巻・号 | 26(2) |
| ページ | 305-313 |
| 公開日 | 2022-2-1 |
| DOI | 10.1007/s11605-021-05101-2 |
| PII | 10.1007/s11605-021-05101-2 |
| PMID | 34379296 |
| PMC | PMC8821072 |
| MeSH | Biomarkers Humans Membrane Proteins / metabolism Membrane Proteins / therapeutic use Prognosis Serine Endopeptidases / genetics Serine Endopeptidases / metabolism Stomach Neoplasms* / drug therapy Stomach Neoplasms* / genetics Stomach Neoplasms* / pathology |
| IF | 2.573 |
| リソース情報 | |
| ヒト・動物細胞 | MKN45(RCB1001) |